Unknown

Dataset Information

0

A distinctive evolution of alveolar T cell responses is associated with clinical outcomes in unvaccinated patients with SARS-CoV-2 pneumonia.


ABSTRACT: Pathogen clearance and resolution of inflammation in patients with pneumonia require an effective local T cell response. Nevertheless, local T cell activation may drive lung injury, particularly during prolonged episodes of respiratory failure characteristic of severe SARS-CoV-2 pneumonia. While T cell responses in the peripheral blood are well described, the evolution of T cell phenotypes and molecular signatures in the distal lung of patients with severe pneumonia caused by SARS-CoV-2 or other pathogens is understudied. Accordingly, we serially obtained 432 bronchoalveolar lavage fluid samples from 273 patients with severe pneumonia and respiratory failure, including 74 unvaccinated patients with COVID-19, and performed flow cytometry, transcriptional, and T cell receptor profiling on sorted CD8+ and CD4+ T cell subsets. In patients with COVID-19 but not pneumonia secondary to other pathogens, we found that early and persistent enrichment in CD8+ and CD4+ T cell subsets correlated with survival to hospital discharge. Activation of interferon signaling pathways early after intubation for COVID-19 was associated with favorable outcomes, while activation of NF-κB-driven programs late in disease was associated with poor outcomes. Patients with SARS-CoV-2 pneumonia whose alveolar T cells preferentially targeted the Spike and Nucleocapsid proteins tended to experience more favorable outcomes than patients whose T cells predominantly targeted the ORF1ab polyprotein complex. These results suggest that in patients with severe SARS-CoV-2 pneumonia, alveolar T cell interferon responses targeting structural SARS-CoV-2 proteins characterize patients who recover, yet these responses progress to NF-κB activation against non-structural proteins in patients who go on to experience poor clinical outcomes.

SUBMITTER: Markov NS 

PROVIDER: S-EPMC10760069 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

A distinctive evolution of alveolar T cell responses is associated with clinical outcomes in unvaccinated patients with SARS-CoV-2 pneumonia.

Markov Nikolay S NS   Ren Ziyou Z   Senkow Karolina J KJ   Grant Rogan A RA   Gao Catherine A CA   Malsin Elizabeth S ES   Sichizya Lango L   Kihshen Hermon H   Helmin Kathryn A KA   Jovisic Milica M   Arnold Jason M JM   Pérez-Leonor Xóchitl G XG   Abdala-Valencia Hiam H   Swaminathan Suchitra S   Nwaezeapu Julu J   Kang Mengjia M   Rasmussen Luke L   Ozer Egon A EA   Lorenzo-Redondo Ramon R   Hultquist Judd F JF   Simons Lacy M LM   Rios-Guzman Estefany E   Misharin Alexander V AV   Wunderink Richard G RG   Budinger G R Scott GRS   Budinger G R Scott GRS   Singer Benjamin D BD   Morales-Nebreda Luisa L  

bioRxiv : the preprint server for biology 20231214


Pathogen clearance and resolution of inflammation in patients with pneumonia require an effective local T cell response. Nevertheless, local T cell activation may drive lung injury, particularly during prolonged episodes of respiratory failure characteristic of severe SARS-CoV-2 pneumonia. While T cell responses in the peripheral blood are well described, the evolution of T cell phenotypes and molecular signatures in the distal lung of patients with severe pneumonia caused by SARS-CoV-2 or other  ...[more]

Similar Datasets

| S-SCDT-EMBOR-2020-51252V1 | biostudies-other
| S-EPMC8654722 | biostudies-literature
| S-SCDT-EMM-2021-14122 | biostudies-other
| S-EPMC11238253 | biostudies-literature
| EMPIAR-10533 | biostudies-other
| S-EPMC11447454 | biostudies-literature
| S-EPMC9527494 | biostudies-literature
| S-SCDT-10_1038-S44318-024-00061-0 | biostudies-other
| S-EPMC9538485 | biostudies-literature
| S-EPMC9881590 | biostudies-literature